Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Endothelial Function: A Systematic Review of Preclinical Studies.
Afnan S AlshnbariSophie A MillarSaoirse E O'SullivanIskandar IdrisPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)
Preclinical studies indicate that SGLT-2 inhibitors attenuate vascular dysfunction in preclinical models via a combination of mechanisms that appear to act independently of glucose-lowering benefits.